MCP-1 also promotes VEGF expression through activation of the CCR2/ILK/MEK1/2 signaling pathway and downregulation of miR-29c, a tumor suppressor microRNA (Lien et al. [109]. The gene discussed is MAP2K1; the disease is neoplasm.